
Boost in Frontline Bevacizumab Use in Ovarian Cancer Linked to Guidelines Inclusion Cancer Therapy Advisor
Addition of bevacizumab to NCCN guidelines as a frontline therapy in ovarian cancer spurred more utilization of the drug than did *fresh* findings from clinical …
“ovarian cancer” – Google News
